SJS Investment Consulting
CSTL icon

SJS Investment Consulting’s Castle Biosciences CSTL Stock Holding History

SJS Investment Consulting’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.3K Buy
459
+444
+2,960% +$13.4K ﹤0.01% 1088
2026
Q2 		$358 Sell
15
-4
-21% -$89 ﹤0.01% 2356
2026
Q1 		$467 Buy
+19
New +$622 ﹤0.01% 1770

Other funds holding CSTL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Kornitzer Capital Management
Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

SJS Investment Consulting's CSTL Position: Q3 2026 in Review

SJS Investment Consulting increased its Castle Biosciences (CSTL) stake by 2,960% in Q3 2026, buying an estimated $13.4K and bringing the position to 459 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

SJS Investment Consulting first reported a position in CSTL in Q1 2026 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • SJS Investment Consulting held 459 shares of Castle Biosciences worth $16.3K as of Q3 2026.
  • SJS Investment Consulting bought 444 Castle Biosciences shares in Q3 2026, an estimated $13.4K.
  • Castle Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1088 holding.
  • SJS Investment Consulting first reported a position in Castle Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.